Indications |
Oral Hyperphosphataemia in end stage renal failure Adult: Initially, 0.75-2.25 g daily, given in divided doses wth meals. Dose may be adjusted every 2-3 wk until an acceptable serum phosphate concentration is achieved; usual maintenance dose: 1.5-3 g daily in divided doses. Max: 3.75 g daily. |
Warnings / Precautions |
Caution when used in patients with acute peptic ulcer, ulcerative colitis, Crohn's disease or bowel obstruction. Tablets should be thoroughly chewed before swallowing. Pregnancy and lactation. |
Adverse Reactions |
GI disturbances, including nausea, vomiting, constipation, diarrhoea, dyspepsia and abdominal pain. |
Overdose Reactions |
Supportive treatment is recommended. |
Drug Interactions |
Compounds that are known to interact with antacids should not be taken within 2 hr of administering lanthanum carbonate. See Below for More lanthanum carbonate Drug Interactions |
Lab Interactions |
Abdominal x-rays of patients taking lanthanum carbonate may have a radio-opaque appearance typical of an imaging agent. |
Mechanism of Actions |
Lanthanum carbonate is a non-calcium, non-aluminium phosphate binder used for hyperphosphataemia in patients with chronic renal failure. It works by inhibiting phosphate absorption by forming highly insoluble lanthanum phosphate complexes, thus reducing both serum phosphate and calcium phosphate product. Distribution: Highly bound to plasma proteins. Metabolism: Not metabolised. Excretion: Eliminated mainly by the biliary system. Elimination half life: Approx 36 hr. |
Administration |
Should be taken with food. (Take w/ or immediately after meals. Chew thoroughly before swallowing. Do not swallow whole.) |
Storage Conditions |
Oral: Store at 15-30°C. |
ATC Classification |
V03AE03 - lanthanum carbonate ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia. |
Storage |
Oral: Store at 15-30°C. |
Available As |
|
Lanthanum Carbonate
Post Review about Lanthanum Carbonate Click here to cancel reply.
Lanthanum Carbonate Containing Brands
Lanthanum Carbonate is used in following diseases
Drug - Drug Interactions of Lanthanum Carbonate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.